Literature DB >> 22050346

Association of an increased frequency of CD14+ HLA-DR lo/neg monocytes with decreased time to progression in chronic lymphocytic leukaemia (CLL).

Michael P Gustafson, Roshini S Abraham, Yi Lin, Wenting Wu, Dennis A Gastineau, Clive S Zent, Allan B Dietz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22050346      PMCID： PMC3433277          DOI： 10.1111/j.1365-2141.2011.08902.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone.

Authors:  Michael P Gustafson; Yi Lin; Kent C New; Peggy A Bulur; Brian Patrick O'Neill; Dennis A Gastineau; Allan B Dietz
Journal:  Neuro Oncol       Date:  2010-02-23       Impact factor: 12.300

2.  Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia.

Authors:  Nobuhiro Tsukada; Jan A Burger; Nathan J Zvaifler; Thomas J Kipps
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

3.  Inflammation, the microenvironment and chronic lymphocytic leukemia.

Authors:  Federico Caligaris-Cappio
Journal:  Haematologica       Date:  2011-03       Impact factor: 9.941

4.  Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells.

Authors:  A E Loercher; M A Nash; J J Kavanagh; C D Platsoucas; R S Freedman
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

5.  Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.

Authors:  Roberta Valenti; Veronica Huber; Paola Filipazzi; Lorenzo Pilla; Gloria Sovena; Antonello Villa; Alessandro Corbelli; Stefano Fais; Giorgio Parmiani; Licia Rivoltini
Journal:  Cancer Res       Date:  2006-09-15       Impact factor: 12.701

6.  Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia.

Authors:  Ana P Gonzalez-Rodriguez; Juan Contesti; Leticia Huergo-Zapico; Alejandro Lopez-Soto; Azahara Fernández-Guizán; Andrea Acebes-Huerta; Ana J Gonzalez-Huerta; Esther Gonzalez; Carmen Fernandez-Alvarez; Segundo Gonzalez
Journal:  Leuk Lymphoma       Date:  2010-10

7.  Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.

Authors:  Yi Lin; Michael P Gustafson; Peggy A Bulur; Dennis A Gastineau; Thomas E Witzig; Allan B Dietz
Journal:  Blood       Date:  2010-11-09       Impact factor: 22.113

8.  Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

Authors:  Stanimir Vuk-Pavlović; Peggy A Bulur; Yi Lin; Rui Qin; Carol L Szumlanski; Xinghua Zhao; Allan B Dietz
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

9.  Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia.

Authors:  Shanique Palmer; Curtis A Hanson; Clive S Zent; Luis F Porrata; Betsy Laplant; Susan M Geyer; Svetomir N Markovic; Timothy G Call; Deborah A Bowen; Diane F Jelinek; Neil E Kay; Tait D Shanafelt
Journal:  Br J Haematol       Date:  2008-04-01       Impact factor: 6.998

10.  A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells.

Authors:  Bastian Hoechst; Lars A Ormandy; Matthias Ballmaier; Frank Lehner; Christine Krüger; Michael P Manns; Tim F Greten; Firouzeh Korangy
Journal:  Gastroenterology       Date:  2008-03-21       Impact factor: 22.682
  10 in total
  33 in total

1.  Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

Authors:  Paolo Giannoni; Gabriella Pietra; Giorgia Travaini; Rodolfo Quarto; Genti Shyti; Roberto Benelli; Laura Ottaggio; Maria Cristina Mingari; Simona Zupo; Giovanna Cutrona; Ivana Pierri; Enrico Balleari; Alessandra Pattarozzi; Marco Calvaruso; Claudio Tripodo; Manlio Ferrarini; Daniela de Totero
Journal:  Haematologica       Date:  2014-02-21       Impact factor: 9.941

2.  Computational algorithm-driven evaluation of monocytic myeloid-derived suppressor cell frequency for prediction of clinical outcomes.

Authors:  Shigehisa Kitano; Michael A Postow; Carly G K Ziegler; Deborah Kuk; Katherine S Panageas; Czrina Cortez; Teresa Rasalan; Mathew Adamow; Jianda Yuan; Philip Wong; Gregoire Altan-Bonnet; Jedd D Wolchok; Alexander M Lesokhin
Journal:  Cancer Immunol Res       Date:  2014-05-20       Impact factor: 11.151

3.  MDSCs: the final frontier of the microenvironment in CLL?

Authors:  Katja Zirlik
Journal:  Blood       Date:  2014-07-31       Impact factor: 22.113

4.  Immunosuppressive monocytes (CD14+/HLA-DRlow/-) increase in childhood precursor B-cell acute lymphoblastic leukemia after induction chemotherapy.

Authors:  D S Lima; R P G Lemes; D M Matos
Journal:  Med Oncol       Date:  2018-02-10       Impact factor: 3.064

5.  Increase in myeloid-derived suppressor cells (MDSCs) associated with minimal residual disease (MRD) detection in adult acute myeloid leukemia.

Authors:  Hui Sun; Yi Li; Zhi-fen Zhang; Ying Ju; Li Li; Bing-chang Zhang; Bin Liu
Journal:  Int J Hematol       Date:  2015-09-10       Impact factor: 2.490

6.  Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity.

Authors:  Rahul Chavan; Daniela Salvador; Michael P Gustafson; Allan B Dietz; Wendy Nevala; Svetomir N Markovic
Journal:  Cancer Immunol Res       Date:  2013-11-18       Impact factor: 11.151

Review 7.  Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies.

Authors:  Peng-Fei Wang; Si-Ying Song; Ting-Jian Wang; Wen-Jun Ji; Shou-Wei Li; Ning Liu; Chang-Xiang Yan
Journal:  Oncoimmunology       Date:  2018-07-30       Impact factor: 8.110

Review 8.  Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia.

Authors:  Audrey Mohr; Yves Renaudineau; Cristina Bagacean; Jacques-Olivier Pers; Christophe Jamin; Anne Bordron
Journal:  Oncoimmunology       Date:  2016-03-16       Impact factor: 8.110

9.  The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.

Authors:  Rossana Maffei; Jenny Bulgarelli; Stefania Fiorcari; Linda Bertoncelli; Silvia Martinelli; Carla Guarnotta; Ilaria Castelli; Silvia Deaglio; Giulia Debbia; Sara De Biasi; Goretta Bonacorsi; Patrizia Zucchini; Franco Narni; Claudio Tripodo; Mario Luppi; Andrea Cossarizza; Roberto Marasca
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

Review 10.  Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia.

Authors:  Christopher Pleyer; Adrian Wiestner; Clare Sun
Journal:  Leuk Lymphoma       Date:  2018-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.